Skip to main content
. 2022 Apr 9;20(2):15593258221092367. doi: 10.1177/15593258221092367

Table 1.

Dose Grid of Study Design.

Patients (n) Dex (μg/kg) Suf (μg/kg [n])
20 0 .2 (5), .3 (5), .4 (5), .5 (5)
20 0.3 .1 (5), .2 (5), .3 (5), .4 (5)
20 0.5 .1 (5), .2 (5), .3 (5), .4 (5)
20 0.7 .1 (5), .2 (5), .3 (5), .4 (5)
20 0.9 .1 (5), .2 (5), .3 (5), .4 (5)
20 1.1 .1 (5), .15 (5), .2 (5), .3 (5)

Dex: dexmedetomidine. Suf: sufentanil.